Dufry to enlist Alibaba as shareholder, signs China JV | Reuters

“China’s Alibaba plans to acquire a stake of up to 9.99% in Swiss duty free group Dufry, Dufry said on Monday, as it announced a new Chinese joint venture with the tech giant.

“Alibaba Group and Dufry AG (Dufry) have agreed to enter into a collaboration to jointly explore and invest in opportunities in China to develop the travel retail business and to enhance Dufry’s digital transformation,” Dufry said in a statement.

The Swiss firm has reeled under the hit of COVID-19 and plans to ask shareholders on Oct. 6 to fund a buyout of its Hudson Ltd unit via a new rights issue.”

Read the full article @ Reuters:

Takeda to sell stake in Chinese JV | The Pharma Letter

Japanese pharma major Takeda (TYO: 4502) is to sell its majority share in Guangdong Techpool Bio-Pharma.

Techpool is a joint venture (JV) that Takeda has held a 51.34% stake in, with a focus on the research, discovery and marketing of urinary protein biopharmaceuticals and production of biopharmaceuticals in critical care.

@ The Pharma Letter | May 22, 2018